610
Views
5
CrossRef citations to date
0
Altmetric
Review

Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement

, , , ORCID Icon & ORCID Icon
Pages 371-381 | Received 11 Dec 2021, Accepted 08 Mar 2022, Published online: 16 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli & Alessandro Granito. (2023) TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert Review of Anticancer Therapy 23:3, pages 279-291.
Read now
Bernardo Stefanini, Matteo Tonnini, Mariarosaria Marseglia & Francesco Tovoli. (2022) Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?. Expert Review of Anticancer Therapy 22:9, pages 887-889.
Read now

Articles from other publishers (3)

Karim Seif El Dahan, Darine Daher & Amit G. Singal. (2023) Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 29:Suppl, pages S207-S219.
Crossref
Luca Ielasi, Bernardo Stefanini, Fabio Piscaglia, Alessandro Granito & Francesco Tovoli. (2023) A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival. Gastroenterology Insights 14:1, pages 38-44.
Crossref
Andreas Teufel, Michael Quante, Arne Kandulski, Michael Hirth, Tianzuo Zhan, Maximilian Eckardt, René Thieme, Nadine Schulte, Sebastian Belle, Isabella Wiest, Christoph Reißfelder, Jürgen F. Riemann, Hans J. Schlitt, Ines Gockel, Peter Malfertheiner & Matthias P. Ebert. (2022) Prävention gastrointestinaler Tumoren. Gastroenterologie up2date 18:03, pages 261-276.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.